Advertisement
Product › Details
bronchospasmolytics & asthma drugs
Next higher product group | pharmaceutical | |
Status | 1998-01-01 sales existent | |
Record changed: 2023-07-10 |
Advertisement
More documents for bronchospasmolytics & asthma drugs
- [1] GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio"....
- [2] AstraZeneca plc. (11/1/21). "Press Release: AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma"....
- [3] Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford....
- [4] Oncopeptides AB. (2/26/21). "Press Release: FDA Approves Oncopeptides' Pepaxto (melphalan flufenamide) for Patients with Relapsed or Refractory Multiple Myeloma". Stockholm....
- [5] Sterna Biologicals GmbH & Co. KG. (1/7/21). "Press Release: Sterna Biologicals Raises further EUR 10.0 Million (approx. USD 11.9 Million) in Series A – 2nd Closing Private Placement". Marburg....
- [6] Sterna Biologicals GmbH & Co. KG. (5/26/20). "Press Release: Sterna Biologicals Secures EUR 12.0 Million (approx. USD 13.0 Million) in Private Placement". Marburg....
- [7] Immune Regulation Ltd.. (3/27/20). "Press Release: Immune Regulation Ltd Appoints Jonathan Rigby as Chief Executive Officer"....
- [8] Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne....
- [9] Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford....
- [10] Sanofi S.A.. (5/7/19). "Press Release: Dupixent (dupilumab) Approved for Severe Asthma by European Commission". Paris & Tarrytown, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top